Stockscreener 앱 받기
1.53
0.00%
0.00
전일 마감가:
$1.53
열려 있는:
$1.53
하루 거래량:
1.80M
Relative Volume:
0.46
시가총액:
$313.56M
수익:
$12.87M
순이익/손실:
$-114.34M
주가수익비율:
-1.7696
EPS:
-0.8646
순현금흐름:
$-79.23M
1주 성능:
-5.56%
1개월 성능:
-17.30%
6개월 성능:
-28.50%
1년 성능:
+6.25%
1일 변동 폭
$1.47
$1.585
1주일 범위
$1.47
$1.75
52주 변동 폭
$1.19
$4.32
Taysha Gene Therapies Inc Stock (TSHA) Company Profile
명칭
Taysha Gene Therapies Inc
전화
(214) 612-0000
주소
3000 PEGASUS PARK DRIVE, DALLAS
TSHA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TSHA
Taysha Gene Therapies Inc
|
1.53 | 313.56M | 12.87M | -114.34M | -79.23M | -0.8646 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-27 | 개시 | BMO Capital Markets | Outperform |
| 2024-04-09 | 개시 | Piper Sandler | Overweight |
| 2023-02-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-01-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-03-09 | 개시 | Robert W. Baird | Outperform |
| 2022-03-01 | 개시 | Wells Fargo | Overweight |
| 2022-02-18 | 개시 | SMBC Nikko | Outperform |
| 2021-12-16 | 개시 | Guggenheim | Buy |
| 2021-07-16 | 개시 | Needham | Buy |
| 2021-06-24 | 개시 | Truist | Buy |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-06-09 | 개시 | Wedbush | Outperform |
| 2021-06-08 | 개시 | JMP Securities | Mkt Outperform |
| 2021-05-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-05-11 | 재개 | Jefferies | Buy |
| 2021-02-24 | 개시 | William Blair | Outperform |
| 2021-01-05 | 개시 | Oppenheimer | Outperform |
| 2020-10-19 | 개시 | Chardan Capital Markets | Buy |
| 2020-10-19 | 개시 | Goldman | Buy |
| 2020-10-19 | 개시 | Jefferies | Buy |
| 2020-10-19 | 개시 | Morgan Stanley | Overweight |
모두보기
Taysha Gene Therapies Inc 주식(TSHA)의 최신 뉴스
Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) PT at $6.63 - MarketBeat
Barclays PLC Increases Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Barclays PLC Boosts Stock Holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
JPMorgan Chase & Co. Boosts Stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Jane Street Group LLC Sells 20,552 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Principal Financial Group Inc. Sells 5,810 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies (NASDAQ:TSHA) Given “Buy” Rating at Needham & Company LLC - Defense World
Assessing Taysha Gene Therapies: Insights From 8 Financial Analysts - Benzinga
Taysha Gene Therapies' (TSHA) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Taysha Gene Therapies Grants 311,000 Stock Options to New Employee Under Inducement Plan - StockTitan
100,795 Shares in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Bought by Franklin Resources Inc. - Defense World
Barclays PLC Buys 193,046 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Geode Capital Management LLC Acquires 682,273 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Geode Capital Management LLC Buys 682,273 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
Analysts Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.63 - Defense World
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Short Interest Update - MarketBeat
State Street Corp Has $6.97 Million Stock Holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Wellington Management Group LLP Buys New Shares in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
The Manufacturers Life Insurance Company Sells 72,548 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies' SWOT analysis: promising rett syndrome stock faces key tests - Investing.com Canada
Thinking about buying stock in Nikola, Delcath Systems, Taysha G - GuruFocus.com
Fmr LLC Has $37.54 Million Stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Sold by Fmr LLC - Defense World
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Up 6.3%Still a Buy? - MarketBeat
Taysha Gene Therapies Issues 152,000-Share Stock Option Grant to New Executive Hire - StockTitan
Canadian Imperial Bank of Commerce (CM-N) QuotePress Release - The Globe and Mail
RTW Investments LP Sells 3,853,879 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
Rett Syndrome Market Forecast: Key Drivers and Opportunities - openPR
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Consensus Price Target from Brokerages - MarketBeat
Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 6.3%Time to Buy? - MarketBeat
Acuta Capital Partners LLC Cuts Stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
TSHA (Taysha Gene Therapies) Dividend Yield % : 0.00% (As of Nov. 26, 2024) - GuruFocus.com
TSHA (Taysha Gene Therapies) EPS without NRI : $-0.29 (TTM As of Sep. 2024) - GuruFocus.com
Realty Income Corp (O-N) QuotePress Release - The Globe and Mail
Taysha Gene Therapies' SWOT analysis: stock poised for growth in Rett syndrome market - Investing.com
TSHA (Taysha Gene Therapies) Days Inventory : 0.00 (As of Sep. 2024) - GuruFocus.com
Amgen (NASDAQ:AMGN) vs. Taysha Gene Therapies (NASDAQ:TSHA) Head-To-Head Comparison - Defense World
TSHA (Taysha Gene Therapies) 5-Day RSI : 71.01 (As of Nov. 24, 2024) - GuruFocus.com
Taysha Gene Therapies (NASDAQ:TSHA) Trading Up 13.8%Here's What Happened - MarketBeat
GSA Capital Partners LLP Raises Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Recent Analysts’ Ratings Updates for Taysha Gene Therapies (TSHA) - Defense World
Canaccord Genuity Group Issues Positive Forecast for Taysha Gene Therapies (NASDAQ:TSHA) Stock Price - Defense World
Neurogene rethinks gene therapy trial after high dose leaves Rett patient in critical condition - Fierce Biotech
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
Expert Outlook: Taysha Gene Therapies Through The Eyes Of 7 Analysts - Benzinga
Taysha Gene Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q3 2024 Earnings Call Transcript - Insider Monkey
Taysha Gene Therapies Inc (TSHA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.81%
자본화:
|
볼륨(24시간):